Research any topic before you write.
Find related topics. | Discover entities. | See connections. | Build a topical map.
Testolactone (INNTooltip International Nonproprietary Name, USANTooltip United States Adopted Name) (brand name Teslac) is a non-selective, irreversible, steroidal aromatase inhibitor which is used as an antineoplastic drug to treat advanced-stage breast cancer. The drug was discontinued in 2008 and is no longer available for medical use.
History, Applications & Measurement
Explore the main themes, entities and connections around Testolactone. Start with the topic map, then use the sections below for research and deeper semantic analysis.
Start with a few of the strongest sections from the source topic. These are research directions, not a list of keywords you must use.
High-confidence facts extracted from structured source data. Use them as anchors for further research.
Browse the full topic structure. Each item opens a new analysis centered on that subject.
Deeper signals for content research, entity SEO and topical coverage. The plain-language headings explain what each technical view is useful for.
See the strongest relationship patterns around the current topic before diving into the raw triples.
Use these terms to understand the vocabulary surrounding the topic, not as a checklist for keyword stuffing.
aromatase drug used breast estrogen medical inhibitor also cancer use side effects available 100 name teslac irreversible women mg synthesis
| Subject | Predicate | Object | Confidence | Src |
|---|---|---|---|---|
| Testolactone | 3D model (JSmol) | Interactive image | 1.00 | infobox |
| Testolactone | AHFS/Drugs.com | Consumer Drug Information | 1.00 | infobox |
| Testolactone | ATC code | none | 1.00 | infobox |
| Testolactone | CAS Number | 968-93-4 Y | 1.00 | infobox |
| Testolactone | ChEBI | CHEBI:9460 N | 1.00 | infobox |
| Testolactone | ChEMBL | ChEMBL1571 N | 1.00 | infobox |
| Testolactone | ChemSpider | 13172 N | 1.00 | infobox |
| Testolactone | CompTox Dashboard (EPA) | DTXSID2023644 | 1.00 | infobox |
| Testolactone | Drug class | Aromatase inhibitor; Antiestrogen | 1.00 | infobox |
| Testolactone | DrugBank | DB00894 Y | 1.00 | infobox |
| Testolactone | ECHA InfoCard | 100.012.304 | 1.00 | infobox |
| Testolactone | Excretion | Urine | 1.00 | infobox |
| Testolactone | Formula | C19H24O3 | 1.00 | infobox |
| Testolactone | IUPHAR/BPS | 7303 | 1.00 | infobox |
| Testolactone | KEGG | D00153 Y | 1.00 | infobox |
| Testolactone | Metabolism | Liver | 1.00 | infobox |
| Testolactone | Molar mass | 300.398 g·mol−1 | 1.00 | infobox |
| Testolactone | Other names | 13-Hydroxy-3-oxo-13,17-secoandrosta-1,4-dien-17-oic acid δ-lactone; SQ-9538; Fludestrin; NSC-12173; NSC-23759 | 1.00 | infobox |
| Testolactone | Protein binding | ~85% | 1.00 | infobox |
| Testolactone | PubChem CID | 13769 | 1.00 | infobox |
| Testolactone | Routes of administration | By mouth | 1.00 | infobox |
| Testolactone | Trade names | Teslac | 1.00 | infobox |
| Testolactone | UNII | 6J9BLA949Q | 1.00 | infobox |
These clusters group vocabulary that occurs around closely connected concepts in the source material.
Bridges can reveal useful research angles that are easy to miss in a flat list of related terms.